What role does enzymatic degradation play in the development of osteoarthritis?

What role does enzymatic degradation play in the development of osteoarthritis?

A hypothesis of the pathological development of OA at the clinical stage of the disease may be summarized by the following: the cartilage matrix break- down produced by proteolytic enzymes releases increased amounts of matrix fragments into fluid, which can promote synovial inflammation.

What enzymes break down cartilage?

Members of each of the four classes of protease – serine/threonine proteases, cysteine proteases, aspartic proteases, and metalloproteases – have been implicated in the degradation of cartilage.

What happens to proteoglycans in osteoarthritis?

The articular cartilage covers the end of the long bones and ensures frictionless motion of the joints. Given these important roles of proteoglycans in regulating cell functions, it is well understandable that loss of ECM and degradation of proteoglycans during OA induce severe changes in cartilage homeostasis.

What is Osteoarthritis pathophysiology?

The pathogenesis of OA involves a degradation of cartilage and remodelling of bone due to an active response of chondrocytes in the articular cartilage and the inflammatory cells in the surrounding tissues.

What is the meaning of degradative enzymes?

A degradative enzyme is an enzyme (in a broader sense a protein) which degrades biological molecules. Some examples of degradative enzymes: Lipase, which digests lipids, Proteases, which digest proteins, Nucleases, which digest nucleic acids.

What factors increase the risk of developing osteoarthritis?

Factors that can increase your risk of osteoarthritis include:

• Older age. The risk of osteoarthritis increases with age.
• Sex. Women are more likely to develop osteoarthritis, though it isn’t clear why.
• Obesity.
• Joint injuries.
• Repeated stress on the joint.
• Genetics.
• Bone deformities.
• Certain metabolic diseases.

What enzyme causes arthritis?

Cartilage degradation results from an imbalance of enzymes that break down connective tissue and their inhibitors. In particular, activity levels of the enzymes MMP-2 and MMP-9 are frequently increased in the cartilage of people suffering from osteoarthritis.

Do proteolytic enzymes help arthritis?

Proteolytic enzymes have many important functions in the body, including helping break down food for energy, and are found in certain foods and supplements. Studies suggest that they can improve digestion, decrease inflammation, ease arthritis pain and possibly reduce symptoms related to IBS.

What are proteoglycans in cartilage?

Cartilage proteoglycans are extracellular macromolecules with complex structure, composed of a core protein onto which a variable number of glycosaminoglycan chains are attached. Their biosynthesis at the glycosaminoglycan level involves a great number of sugar transferases well-orchestrated in Golgi apparatus.

What are proteoglycan molecules in the matrix of cartilage?

Proteoglycans are macromolecules consisting of a protein core to which are attached 50 to 100 unbranched glycosaminoglycans (chondroitin sulfate and O-linked keratan sulfate). At least five different protein cores have been defined. The principal proteoglycan of hyaline cartilage is called aggrecan.

Which joints are affected by osteoarthritis What in the physiology is affected?

It occurs when the protective cartilage that cushions the ends of the bones wears down over time. Although osteoarthritis can damage any joint, the disorder most commonly affects joints in your hands, knees, hips and spine.

What enzymes are involved in cartilage degradation?

The primary enzymes responsible for the degradation of cartilage are the matrix metalloproteinases (MMPs). These enzymes are secreted by both synovial cells and chondrocytes and are categorized into three general categories: a) collagenases; b) stromelysins; and, c) gelatinases.

What is the pathophysiology of osteoarthritis (OA) (OA)?

In OA cartilage, however, matrix degrading enzymes are overexpressed, shifting this balance in favor of net degradation, with resultant loss of collagen and proteoglycans from the matrix. Presumably in response to this loss, chondrocytes initially proliferate and synthesize enhanced amounts of proteoglycan and collagen molecules.

What are the new therapies for osteoarthritis (OA)?

New therapies (see Treatment ), focused on reducing MMP activity and on stimulating matrix synthesis, are in development. Lohmander LS et al. Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine.

Is osteoarthritis (OA) a disease or natural consequence of aging?

A critical question is whether OA is truly a disease or a natural consequence of aging. Several differences between aging cartilage and OA cartilage have been described, suggesting the former. For example, although denatured type II collagen is found in both normal aging and OA cartilage, it is more predominant in OA.